FDA Drug Application (016042) for DYAZIDE by GLAXOSMITHKLINE LLC

Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Application Number016042
Product Number002
FormCAPSULE;ORAL
Dosage25MG;50MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDYAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TRIAMTERENE5


Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC